Mesotherapy for Eye Bags
Ingredient: 12mg/ml Micro cross-linked Hyaluronic Acid, Amino acids, Carnosine, Vitamin B2, Lidocaine hydrochloride
Specification: 1ml
Package: Single package, Sterile
Application Area: Eye
Product Introduction:
Micro-crosslinked sodium hyaluronate excels in maintaining skin smoothness, deeply hydrating while ensuring a natural, bump-free finish. Fades dark circles, smooths under-eye hollows, and improves skin resilience around the eyes. Specifically developed for anti-aging, it addresses dark circles and other signs of aging around the eyes.
Product Display:
Product Details:
Type | |
Specification | 1ml |
Ingredients | Micro cross linked sodium hyaluronic 12mg/ml, amino acids, carnosine, vitamin B2, lidocaine hydrochloride |
Application | Subcutaneous superficial morphological support |
Function | Fade dark circles, smooth tear furrows, increase elasticity around eyes |
Package | Single package, Sterile |
Storage | Room temperature (1-25ºC), cool and dry place |
Recommended | 1-2 pc |
Recommended interval | 1-2 months/time, 3 times in a row |
Product Package:
Customer Feedback:
Raw Material Advantages:
1. Diminishes dark circles, reduces tear troughs, and increases firmness around the eyes. Designed for comprehensive eye care, it effectively fights dark circles and enhances skin elasticity.
2. Formulated with a superior sodium hyaluronate content to ensure long-lasting and effective results. The micro-crosslinked structure prevents uneven texture, repairs wrinkles, and prolongs effectiveness. Contains lidocaine for a soothing experience.
Development Process:
Company Introduction:
With a rich 15-year legacy in the modification and crosslinking of polysaccharide materials, our cutting-edge medical-grade material modification platform converts chitosan into carboxymethyl chitosan—demonstrated by our available surgical anti-adhesion fluid—and transforms sodium hyaluronate into crosslinked sodium hyaluronate through fully mastered biphasic, monophasic, and micro-crosslinking processes, while concurrently advancing medical-grade microsphere production with crosslinked starch microspheres (as in our composite microporous polysaccharide hemostatic powder) and innovative injectable PCL, PLLA, and PMMA microspheres.